Diversification in vaccine suppliers only way to secure millions of doses: Procurement minister
WASHINGTON - The White House tells The Associated Press that the U.S. will begin sharing its entire stock of COVID-19 vaccines from AstraZeneca once the vaccine clears federal safety reviews.
As many as 60-million doses are expected to be available for export in the coming months.
The move greatly expands on the Biden administration's action last month to share about four-million doses of the vaccine with Mexico and Canada.
The Oxford-AstraZeneca drug is widely in use around the world but not yet authorized by the U.S. Food and Drug Administration.
BNN Bloomberg Picks
Twitter adds Bitcoin tipping, pushes further into NFTs
Lululemon to outfit Canadian Olympic, Paralympic athletes through 2028 Games
Toronto broker laughs at Liberals' plan to improve housing affordability
Women's European football winnings doubled, still just 5% of men's
Amazon's early pandemic hiring spree mostly people of colour
Apple bans Fortnite until appeals are exhausted in legal fight